comparemela.com

Latest Breaking News On - Athira pharma - Page 6 : comparemela.com

With 36% ownership, Athira Pharma, Inc (NASDAQ:ATHA) has piqued the interest of institutional investors

Key Insights Significantly high institutional ownership implies Athira Pharma's stock price is sensitive to their.

Athira pharmaAthira pharma incPerceptive advisorsAthira pharmaNstitutional ownershipInstitutional investorsNdividual investors

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders

Ex-Celgene CEO takes the top job at TORL—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesDeepika jalotaAdi hoessMarc fellousMax bayerMolly gibsonDaiichi sankyoHans moebiusRobert califfPaolo martiniJulie tierneyRamin farzanehAdam perlmanRob scottCelia linAbionyx pharma

Alzheimer s clinical trial for fosgonimeton completes enrollment

Alzheimer s clinical trial for fosgonimeton completes enrollment
alzheimersnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alzheimersnewstoday.com Daily Mail and Mail on Sunday newspapers.

Athira pharmaMark littonAlzheimer disease cooperative studyDisease cooperative study activitiesDaily livingDisease assessment scale cognitive subscaleAthira sponsored phase

Mark James Litton Sells 4,820 Shares of Athira Pharma, Inc (NASDAQ:ATHA) Stock

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) CEO Mark James Litton sold 4,820 shares of the business’s stock in a transaction that occurred on Friday, January 5th. The stock was sold at an average price of $2.91, for a total value of $14,026.20. Following the sale, the chief executive officer now directly owns 144,397 […]

Mark james littonAthira pharmaWasatch advisors incDimensional fund advisorsAthira pharma company profileMetlife investment managementAthira pharma incEasterly investment partnersPanagora asset management incGet free reportJames littonLife investment managementAsset managementFund advisorsInvestment partnersAthira pharma daily

Contrasting Athira Pharma (NASDAQ:ATHA) & Scinai Immunotherapeutics (NASDAQ:SCNI)

Scinai Immunotherapeutics (NASDAQ:SCNI – Get Free Report) and Athira Pharma (NASDAQ:ATHA – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of […]

United statesIsrael generalWashington state universityScinai immunotherapeuticsAthira pharmaBiondvax pharmaceuticals ltdScinai immunotherapeutics ltdAthira pharma incBiotechnology incMax planck societyUniversity medical centerNational institutes of health grantGet free reportGiven athira pharmaBiondvax pharmaceuticalsAmyotrophic lateral

vimarsana © 2020. All Rights Reserved.